CClinicalTrials.gg
Status unknownNCT03134274Updated Aug 22, 2017

Study Assessing the Usability and Patient Satisfaction With Digital Urinalysis in the Context of Routine Pre-natal Care.

An interventional study of Dip HBDA in Pregnancy, sponsored by Healthy.io Ltd.. Status unknown at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-08-22.

Sponsored by Healthy.io Ltd. · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Aug 2017), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The study is a home-based, usability study assessing the use of the Dip Home-Based Dipstick Analyzer (HBDA) in the context of prenatal care.

Read the detailed description

300 pregnant women receive home testing kit and smartphone application (Dip HBDA) during regular prenatal visit. They are instructed to conduct a urine test (regular 10 parameter dipstick included in kit) at home using the Dip HBDA. After conducting the urine test, participants are to fill out a short questionnaire regarding ease of use, preference of testing and any problems encountered.

This study only assesses usability and questionnaire outcomes. The results of the test (indications on dipstick) are not subject to the study.

02

Conditions studied

  • Pregnancy
03

In context

Lead sponsor

Healthy.io Ltd. is the lead sponsor of 8 studies on the registry; none are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • English Speaking
  • Own and are familiar with use of a smartphone

Exclusion criteria

Exclusion Criteria:

  • They do not have use of both hands.
  • Are visually impaired (cannot read user manual)
  • Have dementia or mental disorder.
  • Are not able to fill urine receptacle.
  • Are not willing to adhere to study procedures.
  • Do not own or are not familiar with the use of a smartphone.
  • Have no access to a wifi / or cellular data connection at their home.
  • Have impaired vision that prevents them from reading instructions.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Pregnant women

    Pregnant women above the age of 18 years, undergoing routine pre-natal care, who own and are familiar with use of a smartphone receive a Dip HBDA kit for home use.

    Device: Dip HBDA

Interventions

  • DeviceDip HBDA

    Participant receive Dip HBDA semiquantitative urinalyiss kit to be used at home one day after routine prenatal consultation. Dip HBDA consists of a testing kit containing calibration color board, 10 parameter urine dipstick and a urine cup as well as a smartphone application. Application guides participant through the test flow. Dipstick is immersed in urine cup, placed on color board and scanned with smartphone.

06

What researchers measure

Primary outcomes

  1. Ease of use and preference questionnaire

    Questionnaire contains: * Ease of use among pregnant women (Ease of use ranking 1-5 measured) * Problems encountered while doing the test * Likelihood that digital home urine testing would be recommended (Net Promoter Score) * Preference of home testing compared to traditional testing (Prefer home testing, no preference, prefer traditional testing)

    Time frame: 2-3 months

Secondary outcomes

  1. Usability of Dip HBDA

    Success rate in conducting the test at home (i.e. successfully completed/total participants)

    Time frame: 2-3 months

07

Study locations

1 of 1 sites recruiting
  • Johns Hopkins Bayview Medical Center
    Baltimore, Maryland 21224, United States
    • Anne Burke, MD · Contact · aburke@jhmdi.edu · 410-550-0337
    • Anne Burke, MD · Principal investigator
    • Jill Edwardson, MD · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 22, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03134274
Lead sponsor
Healthy.io Ltd.
Collaborators
Johns Hopkins University
Responsible party
Sponsor
First posted
Apr 28, 2017
Start date
May 7, 2017
Primary completion
Oct 2017 (estimated)
Completion
Oct 2017 (estimated)
Last update
Aug 22, 2017

Study contacts

Joel Schoppig, Msc
Contact
joel@healthy.io
+972558852042
Ron Zohar
Contact
ron@healthy.io
Anne Burke, MD
principal investigator · Johns Hopkins Medical

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion